It seems that the anti-apoptotic effect of Bcl-2, which usually correlates with poor clinical outcome or resistance to therapy in tumors other than breast cancer [5, 7, 8], is evident only in cases without hormone receptors and without adjuvant therapy. The gene discussed is NR4A1; the disease is breast carcinoma.